Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories Forward

News   Dec 15, 2017 | Original story from Wyss Institute

 
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories Forward

Single-stranded origami technology is based on design rules that can be used to cross DNA strands in and out of single stranded regions to build large nanostructures. Credit: Molgraphics

 
 
 

RELATED ARTICLES

An Artificial Mole As An Early Warning Sign

News

ETH researchers have developed an early warning system for the four most common types of cancer. Should a tumour develop, a visible mole will appear on the skin.

READ MORE

A New Listeria Species From Costa Rica

News

Listeria costaricensis is the official name given to the new bacterial species, discovered in an industrial drainage area in the Costa Rican province of Alajuela.

READ MORE

Stable Beta-Amyloid Dimers Identified in Alzheimer’s Brains

News

A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Drug Discovery Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE